OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

Regulation (EEC) No 2377/90 is amended as follows:

  1. A..

    Annex I is modified as follows:

    1. 1..

      Anti-infectious agents

      1. 1.2.

        Antibiotics

        1. 1.2.4.

          Macrolides

          Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions

          ‘1.2.4.3.

          Spiramycin

          Sum of spiramycin and neospiramycinBovine300 μg/kgLiver, kidney, fat
          200 μg/kgMuscle
          200 μg/kgMilk
          Chicken400 μg/kgLiver
          300 μg/kgFat + skin
          200 μg/kgMuscle’
    2. 2..

      Antiparasitic agents

      1. 2.2.

        Agents acting against ectoparasites

        1. 2.2.3.

          Organophosphates

          Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions

          ‘2.2.3.1.

          Diazinon

          DiazinonBovine, ovine, caprine,700 μg/kgporcine
          Fat20 μg/kgKidney, liver, muscle
          Bovine, ovine, caprine20 μg/kgMilk’
    3. 3..

      Agents acting on the nervous system

      1. 3.2.

        Agents acting on the autonomic nervous system

        1. 3.2.1.

          Anti-adrenergics

          Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions

          ‘3.2.1.1.

          Carazolol

          CarazololPorcine25 μg/kgLiver, kidney
          5 μg/kgMuscle, fat, + skin’
  2. B..

    In Annex II the following headings are added:

    1. 1..

      Inorganic chemicals

      Pharmacologically Active Substance(s)Animal SpeciesOther provisions

      ‘1.6.

      Hydrochloric acid

      All food producing speciesFor use as excipient

      1.7.

      Sodium dichloroisocyanurate

      Bovine, ovine, caprineFor topical use only’
    2. 2..

      Organic chemicals

      Pharmacologically Active Substance(s)Animal SpeciesOther provisions

      ‘2.20.

      Lecirelin

      Bovine, equidae, rabbit

      2.21.

      Dinoprost tromethamine

      All mammalian species

      2.22.

      Malic acid

      All food producing speciesFor use as excipient

      2.23.

      L-tartaric acid and its mono- and di-basic salt of sodium, potassium and calcium

      Al food producing speciesFor use as excipient

      2.24.

      Benzylalcohol

      All food producing speciesFor use as excipient

      2.25.

      Ethanol

      All food producing speciesFor use as excipient

      2.26.

      N-butanol

      All food producing speciesFor use as excipient’
  3. C..

    Annex III is modified as follows:

    1. 1..

      Anti-infectious agents

      1. 1.2.

        Antibiotics

        1. 1.2.2.

          Macrolides

          Pharmacologically Active substance(s)Marker ResidueAnimal SpeciesMRLsTarget TissuesOther provisions

          ‘1.2.2.1.

          Spiramycin

          SpiramycinPorcine600 μg/kgLiver

          Provisional MRLs expire on 1 July 1997

          MRLs apply to all microbiological active residues expressed as Spiramycin-equivalent

          300 μg/kgKidney, muscle
          200 μg/kgFat

          1.2.2.2.

          Tylosin

          TylosinBovine, Porcine, Poultry100 μg/kgMuscle, liver, kidneyProvisional MRLs expire on 1 July 1997
          Bovine50 μg/kgMilk

          1.2.2.3.

          Erythromycin

          ErythromycinBovine, ovine, porcine, poultry400 μg/kgLiver, kidney, muscle, fat

          Provisional MRLs expire on 1 June 2000

          MRLs apply to all microbiological active residues expressed as Erythromycin-equivalent’

          Bovine, ovine40 μg/kgMilk
          Poultry200 μg/kgEggs
        2. 1.2.4.

          Quinolones

          Pharmacologically Active substance(s)Marker ResidueAnimal SpeciesMRLsTarget TissuesOther provisions

          ‘1.2.4.1.

          Danofloxacin

          DanofloxacinBovine900 μg/kgLiverProvisional MRLs expire on 1 July 1997’
          500 μg/kgKidney
          300 μg/kgMuscle
          200 μg/kgFat
          Chicken1 200 μg/kgLiver, kidney
          600 μg/kgFat + skin
          300 μg/kgMuscle
  4. D..

    Annex IV is modified as follows:

    List of pharmacologically active substances for which no maximum residue limits can be fixed

    ‘5.

    Furazolidon’